Correlation Between Virbac SA and Genfit
Can any of the company-specific risk be diversified away by investing in both Virbac SA and Genfit at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virbac SA and Genfit into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virbac SA and Genfit, you can compare the effects of market volatilities on Virbac SA and Genfit and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virbac SA with a short position of Genfit. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virbac SA and Genfit.
Diversification Opportunities for Virbac SA and Genfit
Weak diversification
The 3 months correlation between Virbac and Genfit is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Virbac SA and Genfit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genfit and Virbac SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virbac SA are associated (or correlated) with Genfit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genfit has no effect on the direction of Virbac SA i.e., Virbac SA and Genfit go up and down completely randomly.
Pair Corralation between Virbac SA and Genfit
Assuming the 90 days trading horizon Virbac SA is expected to under-perform the Genfit. But the stock apears to be less risky and, when comparing its historical volatility, Virbac SA is 1.33 times less risky than Genfit. The stock trades about -0.07 of its potential returns per unit of risk. The Genfit is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 365.00 in Genfit on December 2, 2024 and sell it today you would lose (16.00) from holding Genfit or give up 4.38% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Virbac SA vs. Genfit
Performance |
Timeline |
Virbac SA |
Genfit |
Virbac SA and Genfit Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Virbac SA and Genfit
The main advantage of trading using opposite Virbac SA and Genfit positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virbac SA position performs unexpectedly, Genfit can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genfit will offset losses from the drop in Genfit's long position.Virbac SA vs. Vetoquinol | Virbac SA vs. Trigano SA | Virbac SA vs. Biomerieux SA | Virbac SA vs. Sartorius Stedim Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |